Susan L.
Susan L. Andersen-Navalta, Medfield, MA US
Patent application number | Description | Published |
---|---|---|
20100056488 | CORTICOSTEROID CONJUGATES AND USES THEREOF - The invention features corticosteroids conjugated to either a charged group or a bulky group in a manner that resists in vivo cleavage, the resulting conjugate is a peripherally acting steroid with reduced activity in the central nervous system. The invention provides a method for treating a patient having an inflammatory disease by administering to the patient a corticosteroid conjugate. | 03-04-2010 |
Susan L. Baker, Aliso Viejo, CA US
Patent application number | Description | Published |
---|---|---|
20090063846 | SYSTEMS AND METHODS FOR PREVENTION OF PEER-TO-PEER FILE SHARING - A secure digital content delivery system includes a content provider and a content user. The content provider delivers encrypted content to the content user in response to delivery requests. The content provider generates encryption algorithms on the fly and encrypts the content prior to delivery, using a different encryption algorithm and key for each content delivery. The content user subsequently requests access permission from the content provider, to access the encrypted content. The content provider grants access by generating an executable decryption module on the fly and providing the executable decryption module to the content user. The content user decrypts the content and accesses it on the fly, using the executable decryption module. The accessed content is then re-encrypted using a different encryption algorithm and key, to preserve the integrity of the secure content delivery system. The content delivery system uses a programmably configurable protocol parsing engine to encrypt and decrypt content. | 03-05-2009 |
Susan L. Banovic, Hoschton, GA US
Patent application number | Description | Published |
---|---|---|
20090081397 | System and method for creating high gloss plastic items via the use of styrenic copolymers as a coextruded layer - The present techniques provide multi-layer plastic structures and methods for making such. The multi-layer plastic structures include an inner surface made from a polyolefin resin, and resistant to environmental stress cracking, and an outer surface that includes a styrenic copolymer. The outer surface has a kinetic coefficient of friction with itself of 0.42 and a static coefficient of friction with itself of 0.44. | 03-26-2009 |
20120311971 | SYSTEM AND METHOD FOR CREATING HIGH GLOSS PLASTIC ITEMS VIA THE USE OF STYRENIC COPOLYMERS AS A COEXTRUDED LAYER - The present techniques provide multi-layer plastic structures and methods for making such. The multi-layer plastic structures include an inner surface made from a polyolefin resin, and resistant to environmental stress cracking, and an outer surface that includes a styrenic copolymer. The outer surface has a kinetic coefficient of friction with itself of 0.42 and a static coefficient of friction with itself of 0.44. | 12-13-2012 |
Susan L. Bartyczak, King George, VA US
Patent application number | Description | Published |
---|---|---|
20140026669 | Gas gun fixture to evaluate blast wave on target sample - A test fixture is provided for mounting a sample to a gas gun. The fixture includes a gun barrel mount including an annular enclosure with first and second axial ends, and a sample platform. The mount connects to the gas gun at the first end. The sample platform includes a tubular component having third and fourth axial ends, a pusher disk, an end plate, and a flange. The disk supports the sample and mounts to the end plate. The flange removably attaches to the component at the third end. The end plate removably attaches to the component at the fourth end and to the enclosure at the second end. | 01-30-2014 |
Susan L. Critzer, Dellwood, MN US
Patent application number | Description | Published |
---|---|---|
20110186058 | NASAL VALVE TREATMENT METHOD & APPARATUS - A method and apparatus for treating a nasal valve condition including surgically forming an access path to create a pocket on a side of the patient's nose. The pocket is positioned between a soft tissue layer and opposing surfaces of upper and lower cartilages of the nose. The pocket spans a junction between the upper and lower cartilages. An implant is placed through the access path into the pocket with a length oriented to span the junction. A delivery system for placement of the implant includes a surgical tool for forming the access path and for delivering the implant into the access path. | 08-04-2011 |
20110190883 | NASAL VALVE TREATMENT METHOD & APPARATUS - A method and apparatus for treating a nasal valve condition including surgically forming an access path to create a pocket on a side of the patient's nose. The pocket is positioned between a soft tissue layer and opposing surfaces of upper and lower cartilages of the nose. The pocket spans a junction between the upper and lower cartilages. An implant is placed through the access path into the pocket with a length oriented to span the junction. A delivery system for placement of the implant includes a surgical tool for forming the access path and for delivering the implant into the access path. | 08-04-2011 |
20110190884 | NASAL VALVE TREATMENT METHOD & APPARATUS - A method and apparatus for treating a nasal valve condition including surgically forming an access path to create a pocket on a side of the patient's nose. The pocket is positioned between a soft tissue layer and opposing surfaces of upper and lower cartilages of the nose. The pocket spans a junction between the upper and lower cartilages. An implant is placed through the access path into the pocket with a length oriented to span the junction. A delivery system for placement of the implant includes a surgical tool for forming the access path and for delivering the implant into the access path. | 08-04-2011 |
20130178937 | NASAL VALVE TREATMENT METHOD & APPARATUS - A method and apparatus for treating a nasal valve condition including surgically forming an access path to create a pocket on a side of the patient's nose. The pocket is positioned between a soft tissue layer and opposing surfaces of upper and lower cartilages of the nose. The pocket spans a junction between the upper and lower cartilages. An implant is placed through the access path into the pocket with a length oriented to span the junction. A delivery system for placement of the implant includes a surgical tool for forming the access path and for delivering the implant into the access path. | 07-11-2013 |
20160038279 | NASAL VALVE TREATMENT METHOD & APPARATUS - A method and apparatus for treating a nasal valve condition including surgically forming an access path to create a pocket on a side of the patient's nose. The pocket is positioned between a soft tissue layer and opposing surfaces of upper and lower cartilages of the nose. The pocket spans a junction between the upper and lower cartilages. An implant is placed through the access path into the pocket with a length oriented to span the junction. A delivery system for placement of the implant includes a surgical tool for forming the access path and for delivering the implant into the access path. | 02-11-2016 |
Susan L. Fieldstein, Wilmington, NC US
Patent application number | Description | Published |
---|---|---|
20080241811 | Birthday interview method and kit - A method is described for preserving memories of a child's growth by making annual videos of interviews with the child and permanently storing the videos. The interview is preferably conducted on or near the child's birthday using a list of questions directed to the same subject matter, thereby recording the evolution of the child's views and attitudes over time. Preferably, the interviews are conducted and recorded using a kit that includes a storage container, such as a covered box with indicia indicative of its purpose, a booklet of questions, a list of tips or suggestions, labels, and a sample of an interview. | 10-02-2008 |
Susan L. Fulshaw, Concord, MA US
Patent application number | Description | Published |
---|---|---|
20100153298 | COMPUTERIZED METHODS AND APPARATUSES FOR GUIDING A USER THROUGH A TRANSACTION TO CHANGE A CONTRIBUTION CONFIGURATION IN A DEFINED CONTRIBUTION PLAN - Described are computer-based methods and apparatuses, including computer program products, for guiding a user through a transaction to change a contribution configuration in a defined contribution plan. A request is received by an application from a client device. The application processes the request and plan data associated with a user is retrieved. User interface data is generated by the application and the data is transmitted to the client device. A user interface is displayed which initiates, reviews and executes a transaction to change a current contribution configuration to a suggested contribution configuration without requiring the user to enter any additional information. | 06-17-2010 |
Susan L. Hall, San Bernardino, CA US
Patent application number | Description | Published |
---|---|---|
20100221232 | COMPOSITION AND METHODS FOR OSTEOGENIC GENE THERAPY - The present disclosure provides compositions and methods for increasing bone growth and/or enhancing wound healing, for example, fracture repair. The disclosure provides recombinant nucleic acids useful for promoting bone growth. For example, the disclosure provides recombinant nucleic acids that encode a fibroblast growth factor-2 (FGF-2) analog. The disclosure also provides vectors and cells incorporating these nucleic acids, as well as FGF-2 analogs encode by them. The disclosure also provides a mouse system of bone marrow transplantation and methods for producing as well as methods for using the system. Methods for inducing division and/or inducing differentiation of a hematopoietic stem cell are also provided, as are methods for enhancing bone growth and/or wound repair (for example, fracture repair). | 09-02-2010 |
20110004947 | COMPOSITIONS AND METHODS FOR OSTEOGENIC GENE THERAPY - The present disclosure provides compositions and methods for increasing bone growth and/or enhancing wound healing, for example, fracture repair. The disclosure provides recombinant nucleic acids useful for promoting bone growth. For example, the disclosure provides recombinant nucleic acids that encode a fibroblast growth factor-2 (FGF-2) analog. The disclosure also provides vectors and cells incorporating these nucleic acids, as well as FGF-2 analogs encode by them. The disclosure also provides a mouse system of bone marrow transplantation and methods for producing as well as methods for using the system. Methods for inducing division and/or inducing differentiation of a hematopoietic stem cell are also provided, as are methods for enhancing bone growth and/or wound repair (for example, fracture repair). | 01-06-2011 |
20140256917 | COMPOSITIONS AND METHODS FOR OSTEOGENIC GENE THERAPY - The present disclosure provides compositions and methods for increasing bone growth and/or enhancing wound healing, for example, fracture repair. The disclosure provides recombinant nucleic acids useful for promoting bone growth. For example, the disclosure provides recombinant nucleic acids that encode a fibroblast growth factor-2 (FGF-2) analog. The disclosure also provides vectors and cells incorporating these nucleic acids, as well as FGF-2 analogs encode by them. The disclosure also provides a mouse system of bone marrow transplantation and methods for producing as well as methods for using the system. Methods for inducing division and/or inducing differentiation of a hematopoietic stem cell are also provided, as are methods for enhancing bone growth and/or wound repair (for example, fracture repair). | 09-11-2014 |
Susan L. Harlocker, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20080226643 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER - Compositions and methods for the therapy and diagnosis of cancer, particularly breast cancer, are disclosed. Illustrative compositions comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly breast cancer. | 09-18-2008 |
20080311109 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER - Compositions and methods for the therapy and diagnosis of cancer, particularly breast cancer, are disclosed. Illustrative compositions comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly breast cancer. | 12-18-2008 |
20110150919 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER - Compositions and methods for the therapy and diagnosis of cancer, particularly breast cancer, are disclosed. Illustrative compositions comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly breast cancer. | 06-23-2011 |
Susan L. Harlocker US
Patent application number | Description | Published |
---|---|---|
20080219988 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER - Compositions and methods for the therapy and diagnosis of cancer, particularly prostate cancer, are disclosed. Illustrative compositions comprise one or more prostate-specific polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly prostate cancer. | 09-11-2008 |
Susan L. Kalled, Concord, MA US
Patent application number | Description | Published |
---|---|---|
20080267965 | Use of Bcma as an Immunoregulatory Agent - The disclosure relates to B-cell maturation antigen (BCMA), a receptor for APRIL and BAFF, and its use as an immunoregulatory agent in treatment of immunological disorders such as multiple sclerosis. The disclosure provides methods and compositions for treating neurodegenerative immunological disorders in mammals by administering soluble BCMA, an antibody against BCMA, or an antibody against a BCMA ligand, e.g., APRIL or BAFF. | 10-30-2008 |
20080268480 | Methods of Evaluating Baff - The present disclosure provides compositions and methods relating to the evaluation of BAFF in a biological sample from a subject. | 10-30-2008 |
20100330066 | Methods for Use with Baff Antagonists - BAFF plays a central role in acquired immunity. The disclosure identifies BAFF-responsive genes that are substantially upregulated by administration of BAFF and substantially downregulated by treatment with a BAFF antagonist. Specific genes are: NF-κB2, CD23, H2-Mβ (the beta chain of H2-DM), Fig-1, and OBF-1. The disclosure provides methods and compositions for: monitoring the activity of a BAFF antagonist in a mammal; monitoring BAFF activity in a mammal; identifying a mammal to be treated with a BAFF antagonist; and related uses. Such methods include detecting one or more molecules selected from the group consisting of Fig-1 molecule, OBF-1 molecule, and H2-Mβ molecule in a biological sample of the mammal, and optionally further detecting NF-κB2 molecule and/or CD23 molecule in the biological sample. | 12-30-2010 |
20110177093 | USE OF BCMA AS AN IMMUNOREGULATORY AGENT - The disclosure relates to B-cell maturation antigen (BCMA), a receptor for APRIL and BAFF, and its use as an immunoregulatory agent in treatment of immunological disorders such as multiple sclerosis. The disclosure provides methods and compositions for treating neurodegenerative immunological disorders in mammals by administering soluble BCMA, an antibody against BCMA, or an antibody against a BCMA ligand, e.g., APRIL or BAFF. | 07-21-2011 |
20120082661 | ANTI-BCMA ANTIBODIES - This invention provides antibodies that recognize the B Cell Maturation Antigen (BCMA) and that bind naïve B cells, plasma cells, and/or memory B cells. The invention further provides methods for depleting naïve B cells, plasma cells, and memory B cells, and for treating B cell-related disorders, including lymphomas and autoimmune diseases. | 04-05-2012 |
20120231481 | METHODS OF EVALUATING BAFF - The present disclosure provides compositions and methods relating to the evaluation of BAFF in a biological sample from a subject. | 09-13-2012 |
20140213470 | METHODS FOR USE WITH BAFF ANTAGONISTS - BAFF plays a central role in acquired immunity. The disclosure identifies BAFF responsive genes that are substantially upregulated by administration of BAFF and substantially downregulated by treatment with a BAFF antagonist. Specific genes are NF-κB2, CD23, H2-Mβ (the beta chain of H2-DM), Fig-1, and OBF-1. The disclosure provides methods and compositions for monitoring the activity of a BAFF antagonist in a mammal; monitoring BAFF activity in a mammal; identifying a mammal to be treated with a BAFF antagonist; and related uses. Such methods include detecting one or more molecules selected from the group consisting of Fig-1 molecule, OBF-1 molecule, and H2-Mβ molecule in a biological sample of the mammal, and optionally further detecting NF-κB2 molecule and/or CD23 molecule in the biological sample. | 07-31-2014 |
20150125460 | ANTI-BCMA ANTIBODIES - This invention provides antibodies that recognize the B Cell Maturation Antigen (BCMA) and that bind naïve B cells, plasma cells, and/or memory B cells. The invention further provides methods for depleting naïve B cells, plasma cells, and memory B cells, and for treating B cell-related disorders, including lymphomas and autoimmune diseases. | 05-07-2015 |
Susan L. Korpela, Woodbury, MN US
Patent application number | Description | Published |
---|---|---|
20140028174 | THERMALLY CONDUCTIVE LED ASSEMBLY - A thermally conductive LED assembly is disclosed. The thermally conductive LED assembly includes an elongate conductor cable having a first conductor and a second conductor extending along a length of the elongate conductor cable and a thermally conducting and electrically insulating polymer layer disposed between first conductor and second conductor and a second electrically insulating polymer layer is disposed on the first conductor or second conductor. The electrically insulating polymer layer having a thermal impedance value in a range from 2.5 to 15 C°-cm2/W and a plurality of light emitting diodes are disposed along the length of the elongate conductor cable. Each light emitting diode is in electrical communication with the first conductor and the second conductor. | 01-30-2014 |
Susan L. Lovasic, Chester, VA US
Patent application number | Description | Published |
---|---|---|
20090247035 | PIPD Comfort Fabrics and Articles Made Therefrom - The invention concerns a fabric useful in apparel and garments comprising an intimate blend of staple fibers, the blend of fibers comprising 55 to 95 parts by weight of a polypyridobisimidazole fiber having an inherent viscosity of greater than 20 dl/g and a tensile modulus of greater than 120 GPa (820 gpd); and 5 to 45 parts by weight of a flexible fiber having a tensile modulus of less than 10 GPa (70 gpd). | 10-01-2009 |
Susan L. Mechesney, Coral Springs, FL US
Patent application number | Description | Published |
---|---|---|
20160128501 | Serving Platter with Interchangeable Decorative Insert - A serving platter with interchangeable decorative insert provides a transparent plate and an inner disc that detachably join through a tab and slot mechanism. The disc is configured with a decorative image, text, or pattern, which conveys a holiday themed or special event. The transparent plate is substantially transparent. The disc rests in a recess in the inner perimeter of the transparent plate. The inner perimeter has a flange. The flange has at least one slot. The tab from the disc rotates in a first direction into the slot to affixes the disc to the transparent plate. Conversely, rotating the tab in a second direction out of the slot detaches the disc from the transparent plate. The L-shape of the slot helps retain the tab in the slot. The tab protrudes from the slot to provide a gripping surface for manipulating the tab. | 05-12-2016 |
Susan L. Mizer, Twinsburg, OH US
Patent application number | Description | Published |
---|---|---|
20090069929 | SYSTEM AND METHOD FOR CREATING CUSTOMIZED MULTI-MEDIA GREETING CARDS VIA A KIOSK - The subject application is directed to a system and method for creating customized, multimedia greeting cards via a kiosk. Template data, associated with greeting card templates, and multimedia data files are first stored in an associated data storage. Indicia are then generated on an associated display corresponding to the greeting card templates. Selection data is received corresponding to a selected greeting card template and a multimedia file is associated with the selected greeting card template. Customization data corresponding to user selected content associated with the selected greeting card template is then received. A greeting card output is thereafter generated in accordance with the received selection data, customization data, and the associated multimedia data file. The greeting card output also includes a visual representation of the selected greeting card template and customization data, as well as an encoding of the multimedia data file | 03-12-2009 |
20090070258 | SYSTEM AND METHOD FOR GENERATION OF CUSTOMIZED CARDS HAVING A GIFT VALUE ASSOCIATED THEREWITH - The subject application is directed to a system and method for generating gift cards. Image data representing gift card formats is first generated on an associated display. A gift card is then selected and text data is received representing text associated with the selected gift card. Gift amount data is then received representing a fungible value associated with the selected gift card. Charge data associated with a cost associated with the gift amount is then received. Encoded data, corresponding to the gift amount, is then generated. Thereafter, a tangible gift card is generated in accordance with the selected gift card format and the received text. In accordance with one embodiment of the subject application, the encoded data is stored on a tangible medium on the tangible gift card. | 03-12-2009 |
Susan L. Mooberry, San Antonio, TX US
Patent application number | Description | Published |
---|---|---|
20140357608 | TACCALONOLIDE MICROTUBULE STABILIZERS - The invention provides epoxytaccalonolide microtubule stabilizers and their use as anti-proliferative microtubule stabilizing agents. | 12-04-2014 |
Susan L. Morris-Natschke, Apex, NC US
Patent application number | Description | Published |
---|---|---|
20080293667 | Lipid analogs for combating tumors - The invention relates to methods of treating viral infections, and in particular hepatitis B virus. The method comprises administering to a subject in need of such treatment an infection-controlling amount of a phospholipid or phospholipid derivative to inhibit the activity of the viral infection. | 11-27-2008 |
20100184718 | Compositions and Methods for Double-Targeting Virus Infections and Targeting Cancer Cells - The invention includes compositions and methods useful for treatment of a virus infection in a mammal by double-targeting the virus (i.e. targeting the virus at more than one stage of the virus life cycle) and thereby inhibiting virus replication. The compositions of the invention include compounds which comprise a phosphocholine moiety covalently conjugated with one or more antiviral agents (e.g. nucleoside analogue, protease inhibitor, etc.) to a lipid backbone. The invention also includes pharmaceutical compositions and kits for use in treatment of a virus infection in mammals. The methods of the invention comprise administering a compound of the invention, a pharmaceutically acceptable salt thereof, or a pharmaceutical composition of the invention, in an amount effective to treat the infection, to a mammal infected with a virus. Additionally, the invention includes compositions and methods useful for combating a cancer in a mammal and for facilitating delivery of a therapeutic agent to a mammalian cell. The compositions of the invention include compounds which comprise an alkyl lipid or phospholipid moiety covalently conjugated with an anticancer agent (e.g. a nucleoside analogue). The invention also includes pharmaceutical compositions and kits for combating a cancer and for facilitating delivery of a therapeutic agent to a mammalian cell. The methods of the invention comprise administering a compound of the invention, a pharmaceutically acceptable salt thereof, or a pharmaceutical composition of the invention, in an amount effective to combat a cancer or to facilitate delivery of a therapeutic agent to a mammalian cell. | 07-22-2010 |
20100273740 | Phospholipids for the Treatment of Infection by Togaviruses, Herpes Viruses and Coronaviruses - Provided are compounds, methods and pharmaceutical compositions for treating a host, especially a human, infected with a togavirus, herpes virus and/or coronavirus, and in particular SARS-CoV, cytomegalovirus or varicella-zoster virus. The method in one embodiment comprises administering to that host an effective amount of an anti-togavirus, anti-herpes virus and/or anti-coronavirus phospholipid or a pharmaceutically acceptable salt or prodrug thereof. The phospholipid compound is, e.g., a 3-alkylamido-2-alkoxypropylphosphocholine compound or salt thereof. The compound may be administered alone or in combination and/or alternation with one or more other anti-viral agents. | 10-28-2010 |
Susan L. Pollyea, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20120016248 | PROTECTIVE LINER FOR USE WITH BLOOD PRESSURE CUFFS - A protective liner for use with a blood pressure measuring cuff includes three layers of material configured to protect a person's skin, wick moisture away from the person's skin, and provide a moisture permeable, microporous barrier to microbes. The protective liner is porous and sufficiently thin so that the protective liner will not substantially interfere with blood pressure monitoring through the protective liner. The three layers of material are configured to wick moisture therethrough away from the person's skin, while substantially preventing passage of microbes therethrough. | 01-19-2012 |
20150157223 | PROTECTIVE LINER FOR USE WITH BLOOD PRESSURE CUFFS - A protective liner for use with a blood pressure measuring cuff includes three layers of material configured to protect a person's skin, wick moisture away from the person's skin, and provide a moisture permeable, microporous barrier to microbes. The protective liner is porous and sufficiently thin so that the protective liner will not substantially interfere with blood pressure monitoring through the protective liner. The three layers of material are configured to wick moisture therethrough away from the person's skin, while substantially preventing passage of microbes therethrough. | 06-11-2015 |
Susan L. Roweton, Raleigh, NC US
Patent application number | Description | Published |
---|---|---|
20080255610 | Adhesive-Containing Wound Closure Device and Method - An article, such as a tissue bonding article, includes a flexible material, a polymerization initiator or rate modifier disposed in or on the flexible material, and a polymerizable adhesive composition permeated throughout at least a portion of the flexible material, where the polymerization initiator or rate modifier is a polymerization initiator or rate modifier for the polymerizable adhesive composition. | 10-16-2008 |
Susan L. Secore, Telford, PA US
Patent application number | Description | Published |
---|---|---|
20100166772 | ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n - The present invention features antigen binding proteins that bind to a region found to have an epitope that can be targeted to provide protection against | 07-01-2010 |
Susan L. Smith, Rossford, OH US
Patent application number | Description | Published |
---|---|---|
20140237949 | Closure Pendant to Indicate Package Opening - A product includes a closure having a radially inner portion, and being removably securable to a container, and a pendant releasably coupled to the radially inner portion of the closure, and being releasable from the closure into the container upon removal of the closure from the container. A package may include the product and a container, wherein the closure is removably secured to a neck of the container to removably close the container, and the pendant is suspended from the closure in an interior of the container neck, such that when the closure is removed from the container, the pendant releases from the closure and drops into the container and is non-removably carried therein to provide an indication that the package has been opened from its original factory sealed condition. | 08-28-2014 |
20140262897 | Container With A Medal - A container may include a wall and a medal retained to the wall by container material of integral one-piece construction with the wall and extending over at least a portion of the medal. The medal and one or more portions of the container adjacent the medal have a shared unique appearance. A package may include a flaccid loop coupled between a closure and a container to which the closure is coupled, and a medal coupled to the flaccid loop. | 09-18-2014 |
Susan L. Spraragen, Ossining, NY US
Patent application number | Description | Published |
---|---|---|
20130132299 | USING NON-TEXTUAL NOTATION FOR DESCRIBING SERVICE RELATED HUMAN EXPERIENCE BASED ON A HIERARCHAL MODEL OF HUMAN NEEDS - A system for describing and analyzing service-related human experience in organizational or commercial environments based on a hierarchical model of needs (e.g. Maslow's hierarchy of needs) is provided herein. The system may include a classifier configured to classify experience states based on a predefined hierarchical model of needs, to yield a classification; a modeler configured to model a real-life environment into a model that includes a set of process instances associated with users; and an experience notation generator configured to: extract experience-related data associated with the users from the model, based on the classification; and represent the experience-related data of each one of the process instance as a non-textual time series, based on the classification. Optionally, the time series may be used to produce reports using an analyzer. The reports may be applied to a remedy engine to generate recommendations for improving the human experience. | 05-23-2013 |
Susan L. Uprichard, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20100099079 | Non-dividing cell-based assay for high throughput antiviral compound screening - The present invention features a cell-based assay that recapitulates all aspects of a viral lifecycle for use in identifying antiviral agents. The assay employs synchronized, non-dividing host cells and a fluorescence resonance energy transfer peptide substrate for monitoring endogenous viral protease activity, which is indicative of viral infection kinetics. | 04-22-2010 |
20110171177 | Compositions and Methods for Inhibiting Entry of a Hepatic Virus - The present invention embraces Niemann-Pick C1-like 1 protein antagonists and agents that inhibit hepatic virus infection for use in the prevention and treatment of a hepatic virus infection. | 07-14-2011 |
20130209401 | COMPOSITIONS AND METHODS FOR INHIBITING ENTRY OF A HEPATIC VIRUS - The present invention embraces Niemann-Pick C1-like 1 protein antagonists and agents that inhibit hepatic virus infection for use in the prevention and treatment of a hepatic virus infection. | 08-15-2013 |
Susan L. Welkos, Frederick, MD US
Patent application number | Description | Published |
---|---|---|
20090022756 | Recombinant F1-V Plague Vaccine - Disclosed herein is a composition comprising a purified fusion protein comprising all or part of F1 antigen of | 01-22-2009 |
20120164156 | Recombinant F1-V Plague Vaccine - Disclosed herein is a method of inducing an immunological response in a subject which comprises administering an immunogenic amount of a purified fusion protein comprising all or part of F1 antigen of | 06-28-2012 |